Coronavirus Disease (COVID-19) Updates

Vaccine Eligibility

Eligible Groups/Ages*

Vaccine Type


Pfizer (Comirnaty)


Moderna (Spikevax) COVID-19

3rd Dose

Booster Dose

Ages 5-11


Ages 12-18



Ages 18+


Ages 75+





Front Line

Essential Workers**


* Ages defined as your age as at December 31, 2021.

** Front Line Essential Workers applies to persons having regular known exposure to persons testing positive for COVID in their position

Eligibility for Ages 5-11

Eligibility for vaccination for the 5-11 group will be based on age at the time of appointment and not the year during which the individual was born as previous clinics were coordinated. If the individual is not at least 5 years of age at the time of the appointment, they will not be able to receive the vaccine.

A Q+A regarding the 5-11 Vaccine Effort can be found here.

What is the difference between a booster dose and a third dose of the COVID vaccine?

Booster doses increase immunity and are being offered on a voluntary basis, after a minimum of six (6) months following a resident’s second dose of a COVID-19 vaccine. A booster contains less vaccine product than a 3rd full dose.  If you are immune-compromised you may be eligible for a 3rd dose instead of a booster so please tell your healthcare provider at your immunization appointment.

A COVID booster is received because over time, the protection you generated from the first two doses may be waning. It’s also possible that the protection that you got from the first two may not work as well against a new strain, such as the delta strain that’s circulating now. The booster is administered to help people maintain their level of immunity for longer.

A third dose of the mRNA COVID-19 vaccines (Pfizer or Moderna) is identical to the first two doses. It is administered to help protect people with weakened immune systems who may not have had a strong enough response to the first two doses of one of the mRNA vaccines.

Updates on 3rd Doses and Booster Doses

Second Doses

The Moderna and Pfizer-BioNTech vaccines are reported to be over 90 per cent efficacious 14 days or more after the first dose.

The second dose ensures stronger, longer-lasting protection against the virus.


  • Recommended that doses be given 3 to 16 weeks apart
  • Approved for people 12 years of age and older.


  • Recommended that doses be given 4 to 16 weeks apart.
  • If the second dose is delayed past the recomended timeframe, the second dose should still be given as soon as possible. You do not have to restart the vaccine series if this happens.
  • Approved for people 12 years of age and older.